Evidence map›Paper›PMID 26376639›Full record

SynthesisMalaria journal2015

Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review.

Dieudonné Makaba Mvumbi, Jean-Marie Kayembe, Hippolyte Situakibanza, Thierry L Bobanga, Célestin N Nsibu, Georges L Mvumbi, Pierrette Melin, Patrick De Mol, Marie-Pierre Hayette

Abstract readSystematic Review
In one paragraph

Synthesis in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Tracking Drug Resistance inInternational journal of molecular sciences · 2025
    Article
  8. Molecular Surveillance of Artemisinin-ResistantInternational journal of environmental research and public health · 2024
    Article
  9. Review
  10. Pathogens (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Comprehensive Review of HumanFrontiers in immunology · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dieudonné Makaba MvumbiBiochemistry and Molecular Biology Unit, Department of Basic Sciences, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. didimvumbi@gmail.com.
Jean-Marie KayembeDepartment of Internal Medicine, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. dr12jmkayembe@yahoo.com.
Hippolyte SituakibanzaDepartment of Tropical Medicine and Infectious Disease, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. hsitua@gmail.com.
Thierry L BobangaDepartment of Tropical Medicine and Infectious Disease, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. tbobanga@gmail.com.
Célestin N NsibuDepartment of Paediatric, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. celnsibu@hotmail.fr.
Georges L MvumbiBiochemistry and Molecular Biology Unit, Department of Basic Sciences, School of Medicine, University of Kinshasa, Kinshasa, DR Congo. mvumbilelo@yahoo.fr.
Pierrette MelinDepartment of Clinical Microbiology, University Hospital of Liège, Liège, Belgium. pierrette.melin@chu.ulg.ac.be.
Patrick De MolDepartment of Clinical Microbiology, University Hospital of Liège, Liège, Belgium. P.DeMol@ulg.ac.be.
Marie-Pierre HayetteDepartment of Clinical Microbiology, University Hospital of Liège, Liège, Belgium. mphayette@chu.ulg.ac.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria cases were estimated to 207 million in 2013. One of the problems of malaria control is the emergence and spread of Plasmodium falciparum strains that become resistant to almost all drugs available. Monitoring drug resistance is essential for early detection and subsequent prevention of the spread of drug resistance by timely changes of treatment policy. This review was performed to gather all data available on P. falciparum molecular resistance in DR Congo, as baseline for future assessments.

methodsThe search for this review was undertaken using the electronic databases PubMed and Google Scholar using the terms "malaria", "Congo", "resistance", "molecular", "antimalarial", "efficacy". Articles were classified based on year of collecting, year of publication, sample size and characteristics, molecular markers analysed and polymorphisms detected.

resultsThirteen articles were included and five genes have been analysed in these studies: pfcrt, pfdhps, pfdhfr, pfmdr1 and K13-propeller. The majority of studies included were not representative of the whole country.

conclusionThis systematic review demonstrates the lack of molecular resistance studies in DRC. Only 13 studies were identified in almost 15 years. The MOH must implement a national surveillance system for monitoring malaria drug resistance and this surveillance should be conducted frequently and country-representative.

Indexed as

Democratic Republic of the CongoDrug ResistanceHumansMalaria, FalciparumMutationPlasmodium falciparum

Identifiers

PMID26376639
PMCPMC4574228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.